Which is your choice? Neoadjuvant doxorubicin hydrochloride and doxetaxel (AD) versus doxorubicin hydrochloride, cyclophosphamide, and paclitaxel (AC-T) in locally advanced breast cancer.
Seok Yun Kang
No relevant relationships to disclose
Jin-Hyuk Choi
No relevant relationships to disclose
Ku Sang Kim
No relevant relationships to disclose